ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,923Medicare Part D Prescriptions Filled, Including Refills

Rank: 187 out of 973

$437K Total Retail Price of All Prescriptions

Rank: 195 out of 973

424 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
10% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 424 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

14% of this provider’s 424 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 8,295 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
SIMVASTATIN 493 474 1 1
LEVOTHYROXINE SODIUM 319 310 2 2
HYDROCODONE-ACETAMINOPHEN 307 289 S3 3 4
LISINOPRIL 276 255 4 3
OMEPRAZOLE 263 242 5 5
FUROSEMIDE 229 222 6 6
HYDROCHLOROTHIAZIDE 195 182 7 11
POTASSIUM CHLORIDE 190 172 8 9
AMLODIPINE BESYLATE 178 164 9 7
CITALOPRAM HBR 172 161 10 14
WARFARIN SODIUM 170 164 11 10
PRAVASTATIN SODIUM 161 153 12 22
TRAMADOL HCL 153 102 13 18
ATORVASTATIN CALCIUM 149 139 14 15
GABAPENTIN 139 132 15 12
MELOXICAM 130 115 16 23
DONEPEZIL HCL 121 111 17 26
METOPROLOL TARTRATE 120 120 18 13
TAMSULOSIN HCL 115 113 19 28
ZOLPIDEM TARTRATE 106 95 20 20
MIRTAZAPINE 101 99 21 43
METFORMIN HCL 96 92 22 8
ATENOLOL 87 78 23 16
ALENDRONATE SODIUM 80 80 24 24
CIPROFLOXACIN HCL 73 71 25 57
CLOPIDOGREL 70 64 26 44
KLOR-CON M10 70 66 26 130
LOSARTAN POTASSIUM 68 67 28 19
GLIPIZIDE ER 62 62 29 135
NOVOLOG 61 61 30 82
PREMARIN 60 43 R 31 116
DOXYCYCLINE HYCLATE 59 53 32 96
SPIRIVA 58 56 33 73
NEXIUM 54 38 34 30
DIGOXIN 51 45 35 32
DILTIAZEM 24HR CD 50 49 36 104
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.